These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7869758

  • 1. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R, Battista R, Viero P, d'Emilio A, Buelli M, Montaldi A, Rambaldi A, Tremul L, Dini E, Barbui T.
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Feb; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L.
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [Abstract] [Full Text] [Related]

  • 4. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 5. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

  • 6. Short term therapy (STT) for acute myelogenous leukaemia (AML).
    Rohatiner AZ, Battista R, Bassan R, Love S, Oza AM, Whelan JS, Lim J, Buelli M, Viero P, D'Emillio A.
    Leukemia; 1992 Aug; 6 Suppl 2():85-8. PubMed ID: 1578952
    [Abstract] [Full Text] [Related]

  • 7. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Eardley AM, Heller G, Warrell RP.
    Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
    [Abstract] [Full Text] [Related]

  • 8. High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
    Lengfelder E, Haferlach C, Saussele S, Haferlach T, Schultheis B, Schnittger S, Ludwig WD, Staib P, Aul C, Grüneisen A, Kern W, Reichle A, Serve H, Berdel WE, Braess J, Spiekermann K, Wörmann B, Sauerland MC, Heinecke A, Hiddemann W, Hehlmann R, Büchner T, German AML Cooperative Group.
    Leukemia; 2009 Dec; 23(12):2248-58. PubMed ID: 19741727
    [Abstract] [Full Text] [Related]

  • 9. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
    Esteve J, Escoda L, Martín G, Rubio V, Díaz-Mediavilla J, González M, Rivas C, Alvarez C, González San Miguel JD, Brunet S, Tomás JF, Tormo M, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA, Spanish Cooperative Group PETHEMA.
    Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
    [Abstract] [Full Text] [Related]

  • 10. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 11. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 12. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
    Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH.
    Blood; 2002 Dec 15; 100(13):4298-302. PubMed ID: 12393590
    [Abstract] [Full Text] [Related]

  • 13. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Dec 15; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ, Morales-Toquero A, Gómez-Rangel JD, López-Martínez B, Ruiz-Delgado GJ, Reyes-Núñez V.
    Rev Invest Clin; 2005 Dec 15; 57(3):415-9. PubMed ID: 16187701
    [Abstract] [Full Text] [Related]

  • 16. Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.
    Head DR, Kopecky KJ, Willman C, Appelbaum FR.
    Leukemia; 1994 Dec 15; 8 Suppl 2():S38-41. PubMed ID: 7815835
    [Abstract] [Full Text] [Related]

  • 17. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ, Hester JP, Dixon DO, Khorana S, Keating MJ.
    Hematol Pathol; 1989 Dec 15; 3(1):23-8. PubMed ID: 2745357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M, Matsushita T, Asou N, Kishimoto Y, Tsuzuki M, Maeda Y, Horikawa K, Okada M, Ohtake S, Yagasaki F, Matsumoto T, Kimura Y, Shinagawa K, Iwanaga M, Miyazaki Y, Ohno R, Naoe T.
    Eur J Haematol; 2007 Mar 15; 78(3):213-9. PubMed ID: 17241371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.